Network of instruction stations
    1.
    发明申请
    Network of instruction stations 审中-公开
    指挥站网络

    公开(公告)号:US20070143130A1

    公开(公告)日:2007-06-21

    申请号:US11401086

    申请日:2006-04-10

    申请人: Thomas Hearn

    发明人: Thomas Hearn

    IPC分类号: G06Q99/00

    CPC分类号: G06Q10/10 G06Q50/20

    摘要: In an embodiment, a student may be provided with instructions via computer in an area in which illustrating the physical positioning of the human body or other object may be beneficial. In an embodiment a system of one or more instruction stations may be provided where the student may record practice sessions and/or view prerecorded lessons without the presence of the instructor. In an embodiment, at a later date the instructor may view the recorded practice sessions, and prepare a video that may include a critique of the recorded practice session and/or a new lesson. In an embodiment, a student may initiate the video or lesson review process at any time from any number of devices having access to one or more networks having the source video file saved on any number of devices accessible by the network.

    摘要翻译: 在一个实施例中,可以在说明人体或其他物体的物理定位可能是有益的区域中通过计算机向学生提供指令。 在一个实施例中,可以提供一个或多个指示站的系统,其中学生可以记录练习会话和/或查看预先记录的课程而不存在教练的存在。 在一个实施例中,在稍后的日期,教练可以查看记录的实践课程,并准备可以包括对记录练习课程的批判和/或新课程的视频。 在一个实施例中,学生可以在任何时间从具有访问一个或多个网络的设备的任何数量的设备发起视频或课程审查过程,该网络具有保存在网络可访问的任何数量的设备上的源视频文件。

    Diagnosis and therapy of conditions by detection or modulation of the alms1 gene or protein
    3.
    发明申请
    Diagnosis and therapy of conditions by detection or modulation of the alms1 gene or protein 审中-公开
    通过检测或调节alms1基因或蛋白质来诊断和治疗病症

    公开(公告)号:US20050214757A1

    公开(公告)日:2005-09-29

    申请号:US10492634

    申请日:2002-10-15

    IPC分类号: C07K14/47 C12Q1/68 G01N33/68

    摘要: A method of diagnosing the presence of, or susceptibility to, retinal dystrophy, cardiomyopathy endocrinopathy, diabetes or Alstrom disease in an individual, which method comprises typing in a sample from the individual the ALMS1 protein or ALMS1 gene region of the individual, or detecting aberrant ALMS1 activity, and thereby determining whether the individual has, or is susceptible to, retinal dystrophy, cardiomyopathy, endocrinopathy, diabetes or Alstrom disease. Use of an agent that modulates (i) the ALMS1 protein, or (ii) a component that affects or is affected by ALMS1, in the manufacture of a medicament for prevention or treating retinal dystrophy, cardiomyopathy, endocrinopathy, diabetes or Alstrom disease.

    摘要翻译: 诊断个体视网膜营养不良症,心肌病内分泌病,糖尿病或阿尔斯特罗姆病的存在或易感性的方法,该方法包括从个体的个体的样品中分离个体的ALMS1蛋白或ALMS1基因区域,或检测异常 ALMS1活性,从而确定个体是否具有视网膜营养不良,心肌病,内分泌病,糖尿病或阿尔斯特罗姆病。 在制备用于预防或治疗视网膜营养不良,心肌病,内分泌病,糖尿病或阿尔斯特罗姆病的药物中调节(i)ALMS1蛋白或(ii)影响或受ALMS1影响的组分)的药剂的用途的用途。